Try our Advanced Search for more refined results

3 Firms Help Blueprint Medicine Get $1.25B Investment

By Elaine Briseño (June 30, 2022, 5:21 PM EDT) -- Life science investors Sixth Street and Royalty Pharma announced Thursday they would invest up to $1.25 billion in Blueprint Medicines Corp. to expand commercial opportunities for two drugs that treat certain blood disorders and forms of cancer, in an agreement shaped by three law firms....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!